{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:16:18Z","timestamp":1782980178082,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.biopha.2020.111160","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T08:46:56Z","timestamp":1608886016000},"page":"111160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Affinity-based protein profiling to reveal targets of puerarin involved in its protective effect on cardiomyocytes"],"prefix":"10.1016","volume":"134","author":[{"given":"Shuai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Xiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.111160_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2020.111160_bib0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0167-5273(15)31026-3","article-title":"Global burden of CVD: focus on secondary prevention of cardiovascular disease","volume":"201","author":"Bansilal","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2020.111160_bib0015","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/CIR.0b013e318267e99f","article-title":"Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke)","volume":"126","author":"Smith","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2020.111160_bib0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4239\/wjd.v5.i4.444","article-title":"Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?","volume":"5","author":"Martin-Timon","year":"2014","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.biopha.2020.111160_bib0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s00059-002-2430-3","article-title":"Oxidative stress and apoptosis in heart dysfunction","volume":"27","author":"Kumar","year":"2002","journal-title":"Herz"},{"key":"10.1016\/j.biopha.2020.111160_bib0030","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jep.2011.02.001","article-title":"Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases","volume":"134","author":"Wong","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2020.111160_bib0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jcph.96","article-title":"An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use","volume":"53","author":"Zhang","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111160_bib0040","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/cbf.3026","article-title":"The protective effects of puerarin in cardiomyocytes from anoxia\/reoxygenation injury are mediated by PKC\u03b5","volume":"32","author":"Tang","year":"2014","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.biopha.2020.111160_bib0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.freeradbiomed.2009.10.040","article-title":"Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2\/Rac1-dependent signaling","volume":"48","author":"Zhu","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2020.111160_bib0050","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/10286020.2017.1405941","article-title":"Puerarin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of inflammation","volume":"21","author":"Yin","year":"2019","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2020.111160_bib0055","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3389\/fphar.2018.00540","article-title":"Nrf2 is a key regulator on puerarin preventing cardiac fibrosis and upregulating metabolic enzymes UGT1A1 in rats","volume":"9","author":"Cai","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111160_bib0060","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bmc.2011.06.066","article-title":"Diazirine based photoaffinity labeling","volume":"20","author":"Dubinsky","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2020.111160_bib0065","first-page":"645","article-title":"Conformational study of 8-C-glucosyl-prunetin by dynamic NMR spectroscopy","volume":"13","author":"Zhang","year":"2002","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.biopha.2020.111160_bib0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12935-020-01263-2","article-title":"Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation","volume":"20","author":"Gong","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2020.111160_bib0075","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM199306103282306","article-title":"Long-term complications of diabetes mellitus","volume":"328","author":"Nathan","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.111160_bib0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jdiacomp.2016.06.013","article-title":"Inpatient glycemic variability and long-term mortality in hospitalized patients with type 2 diabetes","volume":"31","author":"Timmons","year":"2017","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.biopha.2020.111160_bib0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.303584","article-title":"Regulation of signal transduction by reactive oxygen species in the cardiovascular system","volume":"116","author":"Brown","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2020.111160_bib0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2017.05.034","article-title":"Basic biology of oxidative stress and the cardiovascular system: part 1 of a 3-Part Series","volume":"70","author":"Sack","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2020.111160_bib0095","first-page":"1108","article-title":"Puerarin improves cardiac function through regulation of energy metabolism in Streptozotocin-Nicotinamide induced diabetic mice after myocardial infarction","volume":"463","author":"Cheng","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2020.111160_bib0100","doi-asserted-by":"crossref","first-page":"14418","DOI":"10.1039\/C9DT03216A","article-title":"Ferrocenyl naphthalenes: substituent- and substitution pattern-depending charge transfer studies","volume":"48","author":"Preu\u00df","year":"2019","journal-title":"Dalton Trans."},{"key":"10.1016\/j.biopha.2020.111160_bib0105","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/10286020.2010.505563","article-title":"The synthesis of puerarin derivatives and their protective effect on the myocardial ischemia and reperfusion injury","volume":"12","author":"Feng","year":"2010","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2020.111160_bib0110","doi-asserted-by":"crossref","first-page":"109748","DOI":"10.1016\/j.biopha.2019.109748","article-title":"CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma","volume":"123","author":"Di","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.111160_bib0115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1471-2407-13-192","article-title":"High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression","volume":"13","author":"Shen","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2020.111160_bib0120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbagrm.2015.05.009","article-title":"The role of the chromatin assembly complex (CAF-1) and its p60 subunit (CHAF1b) in homeostasis and disease","volume":"1849","author":"Volk","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2020.111160_bib0125","first-page":"5409","article-title":"Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: an investigation based on GEO and TCGA databases","volume":"17","author":"Wei","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2020.111160_bib0130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fphar.2018.00847","article-title":"UBE2C is a potential biomarker of intestinal-type gastric cancer with chromosomal instability","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111160_bib0135","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/MCB.24.7.2853-2862.2004","article-title":"Silencing of chromatin assembly factor 1 in human cells leads to cell death and loss of chromatin assembly during DNA synthesis","volume":"24","author":"Nabatiyan","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2020.111160_bib0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopha.2020.111160_bib0145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.chembiol.2019.11.010","article-title":"Identification of a small compound targeting PKM2-regulated signaling using 2D gel electrophoresis-based proteome-wide CETSA","volume":"27","author":"Nagasawa","year":"2020","journal-title":"Cell Chem. Bio."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220313536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220313536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:06:49Z","timestamp":1760098009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220313536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":29,"alternative-id":["S0753332220313536"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111160","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Affinity-based protein profiling to reveal targets of puerarin involved in its protective effect on cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111160"}}